GLSV news
30.01.2012 Global Life Science Ventures: 2011 Review
more...
24.01.2011 Global Life Science Ventures: 2010 Review
more...
14.01.2010 Global Life Science Ventures: 2009 Review
more...
13.02.2009 Global Life Science Ventures: 2008 highlights
more...
22.04.2008 GLSV receives 2007 Dyodelta European Life Science Innovation Award "Investor of the Year Award"
more...
Portfolio company news
03.05.2012 Abbott to Acquire Action Pharma's Investigational Compound, AP214, in Phase 2b Development for Prevention of Acute Kidney Injury
more...
25.04.2012 Henrik Stage Appointed Interim CEO of Santaris Pharma A/S
more...
19.04.2012 Santaris Pharma A/S presents final Phase 2a study results for miravirsen showing dose-dependent, prolonged antiviral activity in Hepatitis C patients
more...
05.04.2012 Zalicus Discovers Novel Multi-Target Mechanism for the Treatment of Multiple Myeloma
more...
04.04.2012 Pieris Presents Preclinical Data for PRS-110 c-Met Antagonist Anticalin at the AACR Annual Meeting
more...

